On the other hand, in the advanced stage of the tumor, TGF-β has a pro-tumorigenic effect, promoting genomic mutations and events associated with the malignant progression of cancer, such as EMT, angiogenesis, inhibition of the immune response, cell motility, and thus the promotion of metastases [4,8]. Here, TGFB1 is linked to cancer.